• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1例与恶性肿瘤相关的抗TIF1γ抗体阳性皮肌炎病例。

A Case of Anti-TIF1γ Antibody-Positive Dermatomyositis Associated With Malignancy.

作者信息

Yasir Muhammad, Abdelgabar Abdelnassir, Elsayed Mohammed, Hasan Md Nayeem, Osman Sherif

机构信息

Acute Medicine, Diana, Princess of Wales Hospital, Grimsby, GBR.

出版信息

Cureus. 2025 Jun 13;17(6):e85930. doi: 10.7759/cureus.85930. eCollection 2025 Jun.

DOI:10.7759/cureus.85930
PMID:40656265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12256074/
Abstract

Dermatomyositis (DM) is a rare acquired autoimmune myopathy characterized by proximal muscle weakness, inflammation, and a typical skin rash. It is considered one of the idiopathic inflammatory myopathies (IIM), a group of heterogeneous systemic diseases that include DM, polymyositis, and inclusion body myositis. A significant portion of patients with IIM, particularly adults, can have an association with malignancy, usually preceded by muscle and skin symptoms. We report a case of a 67-year-old man who presented to the accident and emergency department with a six-week history of proximal myopathy in the upper and lower limbs and a skin rash. After a series of investigations, the patient was diagnosed with anti-TIF1γ-positive DM and concurrent lung cancer. DM is a paraneoplastic disorder that should always prompt a search for malignancy. Early detection of anti-TIF1γ autoantibodies can facilitate an early diagnosis of CAD, allowing for prompt therapeutic interventions. Several autoantibodies with different clinical and prognostic significance have been detected in IIM. However, the recently discovered anti-TIF1γ antibodies appear to be strongly associated with malignancy.

摘要

皮肌炎(DM)是一种罕见的获得性自身免疫性肌病,其特征为近端肌无力、炎症和典型的皮疹。它被认为是特发性炎性肌病(IIM)之一,这是一组异质性全身性疾病,包括皮肌炎、多发性肌炎和包涵体肌炎。相当一部分IIM患者,尤其是成年人,可能与恶性肿瘤有关,通常在出现肌肉和皮肤症状之前。我们报告一例67岁男性患者,他因上下肢近端肌病伴皮疹6周就诊于急诊科。经过一系列检查,该患者被诊断为抗TIF1γ阳性皮肌炎并并发肺癌。皮肌炎是一种副肿瘤性疾病,应始终促使医生寻找恶性肿瘤。早期检测抗TIF1γ自身抗体有助于早期诊断皮肌炎,从而能够及时进行治疗干预。在IIM中已检测到几种具有不同临床和预后意义的自身抗体。然而,最近发现的抗TIF1γ抗体似乎与恶性肿瘤密切相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ca/12256074/1ef8a240d98d/cureus-0017-00000085930-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ca/12256074/5f5b9e1d2f08/cureus-0017-00000085930-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ca/12256074/ce58cd1212ba/cureus-0017-00000085930-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ca/12256074/1ae0a7d4c94b/cureus-0017-00000085930-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ca/12256074/8947df535ee6/cureus-0017-00000085930-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ca/12256074/2805b08740fe/cureus-0017-00000085930-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ca/12256074/1ef8a240d98d/cureus-0017-00000085930-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ca/12256074/5f5b9e1d2f08/cureus-0017-00000085930-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ca/12256074/ce58cd1212ba/cureus-0017-00000085930-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ca/12256074/1ae0a7d4c94b/cureus-0017-00000085930-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ca/12256074/8947df535ee6/cureus-0017-00000085930-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ca/12256074/2805b08740fe/cureus-0017-00000085930-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ca/12256074/1ef8a240d98d/cureus-0017-00000085930-i06.jpg

相似文献

1
A Case of Anti-TIF1γ Antibody-Positive Dermatomyositis Associated With Malignancy.1例与恶性肿瘤相关的抗TIF1γ抗体阳性皮肌炎病例。
Cureus. 2025 Jun 13;17(6):e85930. doi: 10.7759/cureus.85930. eCollection 2025 Jun.
2
A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.成人起病的临床无肌病性皮肌炎(无肌性皮肌炎)的系统评价:特发性炎性肌病谱系中的缺失环节
J Am Acad Dermatol. 2006 Apr;54(4):597-613. doi: 10.1016/j.jaad.2005.10.041. Epub 2006 Jan 23.
3
Anti-Sp4 and anti-CCAR1 autoantibodies in UK vs US patients with adult and juvenile-onset anti-TIF1γ-positive myositis.英国与美国成年及青少年起病的抗TIF1γ阳性肌炎患者中的抗Sp4和抗CCAR1自身抗体
Rheumatology (Oxford). 2025 Jun 1;64(6):3900-3905. doi: 10.1093/rheumatology/keae574.
4
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
6
The Role of Myositis-Specific Autoantibodies and the Management of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies: A Systematic Review.特发性炎性肌病中肌炎特异性自身抗体的作用及间质性肺病的治疗:系统评价。
Semin Arthritis Rheum. 2022 Dec;57:152088. doi: 10.1016/j.semarthrit.2022.152088. Epub 2022 Aug 31.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
Use of Janus kinase inhibitors in dermatomyositis: a systematic literature review.Janus 激酶抑制剂在皮肌炎中的应用:系统文献综述。
Clin Exp Rheumatol. 2023 Mar;41(2):348-358. doi: 10.55563/clinexprheumatol/hxin6o. Epub 2022 Jun 28.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
10
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.

本文引用的文献

1
Dermatomyositis and malignancy: should all patients with dermatomyositis undergo malignancy screening?皮肌炎与恶性肿瘤:所有皮肌炎患者都应接受恶性肿瘤筛查吗?
Ann Transl Med. 2021 Mar;9(5):432. doi: 10.21037/atm-20-5215.
2
Risk factors for cancer-associated myositis: A large-scale multicenter cohort study.癌症相关肌炎的危险因素:一项大规模多中心队列研究。
Int J Rheum Dis. 2021 Feb;24(2):268-273. doi: 10.1111/1756-185X.14046. Epub 2020 Dec 26.
3
The polymorphous spectrum of dermatomyositis: classic features, newly described skin lesions, and rare variants.
皮肌炎的多态性谱:经典特征、新描述的皮肤损伤和罕见变异。
Eur J Dermatol. 2020 Jun 1;30(3):229-242. doi: 10.1684/ejd.2020.3761.
4
Risk Factors and Cancer Screening in Myositis.肌炎的风险因素与癌症筛查。
Rheum Dis Clin North Am. 2020 Aug;46(3):565-576. doi: 10.1016/j.rdc.2020.05.006. Epub 2020 Jun 7.
5
The role of cancer-associated autoantibodies as biomarkers in paraneoplastic myositis syndrome.癌症相关自身抗体作为副肿瘤性肌炎综合征生物标志物的作用。
Curr Opin Rheumatol. 2019 Nov;31(6):643-649. doi: 10.1097/BOR.0000000000000641.
6
Autoantibodies in myositis.肌炎中的自身抗体。
Nat Rev Rheumatol. 2018 Apr 20;14(5):290-302. doi: 10.1038/nrrheum.2018.56.
7
Evidence supports blind screening for internal malignancy in dermatomyositis: Data from 2 large US dermatology cohorts.有证据支持对皮肌炎患者进行隐匿性内脏恶性肿瘤筛查:来自美国两个大型皮肤科队列的数据。
Medicine (Baltimore). 2018 Jan;97(2):e9639. doi: 10.1097/MD.0000000000009639.
8
Risk of Malignancy in Dermatomyositis and Polymyositis.皮肌炎和多发性肌炎中的恶性肿瘤风险
J Cutan Med Surg. 2017 Mar/Apr;21(2):131-136. doi: 10.1177/1203475416665601. Epub 2016 Aug 20.
9
Myositis-specific autoantibodies: an important tool to support diagnosis of myositis.肌炎特异性自身抗体:支持肌炎诊断的重要工具。
J Intern Med. 2016 Jul;280(1):8-23. doi: 10.1111/joim.12451. Epub 2015 Nov 25.
10
TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.TIF1γ干扰TGFβ1/SMAD4信号传导,从而导致可手术乳腺癌患者预后不良。
BMC Cancer. 2015 Jun 4;15:453. doi: 10.1186/s12885-015-1471-y.